Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Roberts

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
Neuroreport|December 30, 1994
Increased numbers of beta APP-immunoreactive neurones in the entorhinal cortex after head injuryJ E McKenzie, S M Gentleman, G W Roberts, et al.
Lancet (London, England)|January 5, 1991
Beta (A4)-amyloid protein and parkinsonian dementia complex of GuamS M Gentleman, D Perl, D Allsop, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|September 1, 1995
Quantification of beta APP immunoreactive pre-alpha cells in the entorhinal cortex using image analysisJ E McKenzie, S M Gentleman, G W Roberts, et al.
Histochemistry|January 1, 1989
A demonstration of the advantages of immunostaining in the quantification of amyloid plaque depositsS M Gentleman, C Bruton, D Allsop, et al.
The New England Journal of Medicine|November 6, 1986
Prion-protein immunoreactivity in human transmissible dementiasG W Roberts, R Lofthouse, R Brown, et al.
Brain Research|December 29, 1989
Distribution of galanin-like immunoreactivity in the human brainS M Gentleman, P Falkai, B Bogerts, et al.
Neuroscience Letters|February 17, 1992
Quantitative differences in the deposition of beta A4 protein in the sulci and gyri of frontal and temporal isocortex in Alzheimer's diseaseS M Gentleman, D Allsop, C J Bruton, et al.
Neuroscience|April 1, 1994
The distribution of nitric oxide synthase immunoreactivity in the human brainY I Egberongbe, S M Gentleman, P Falkai, et al.
International Journal of Clinical Practice. Supplement|February 29, 2000
Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine. Sumatriptan Tablets S2CM10 Study GroupA J Dowson, E A Ashford, S Prendergast, et al.
The Annals of Pharmacotherapy|January 1, 1994
Peripheral intravenous line survival and phlebitis prevention in patients receiving intravenous antibiotics: heparin/hydrocortisone versus in-line filtersG W Roberts, M D Holmes, R E Staugas, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Neuroreport|December 30, 1994
Increased numbers of beta APP-immunoreactive neurones in the entorhinal cortex after head injuryJ E McKenzie, S M Gentleman, G W Roberts, et al.
Lancet (London, England)|January 5, 1991
Beta (A4)-amyloid protein and parkinsonian dementia complex of GuamS M Gentleman, D Perl, D Allsop, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|September 1, 1995
Quantification of beta APP immunoreactive pre-alpha cells in the entorhinal cortex using image analysisJ E McKenzie, S M Gentleman, G W Roberts, et al.
Histochemistry|January 1, 1989
A demonstration of the advantages of immunostaining in the quantification of amyloid plaque depositsS M Gentleman, C Bruton, D Allsop, et al.
The New England Journal of Medicine|November 6, 1986
Prion-protein immunoreactivity in human transmissible dementiasG W Roberts, R Lofthouse, R Brown, et al.
Brain Research|December 29, 1989
Distribution of galanin-like immunoreactivity in the human brainS M Gentleman, P Falkai, B Bogerts, et al.
Neuroscience Letters|February 17, 1992
Quantitative differences in the deposition of beta A4 protein in the sulci and gyri of frontal and temporal isocortex in Alzheimer's diseaseS M Gentleman, D Allsop, C J Bruton, et al.
Neuroscience|April 1, 1994
The distribution of nitric oxide synthase immunoreactivity in the human brainY I Egberongbe, S M Gentleman, P Falkai, et al.
International Journal of Clinical Practice. Supplement|February 29, 2000
Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine. Sumatriptan Tablets S2CM10 Study GroupA J Dowson, E A Ashford, S Prendergast, et al.
The Annals of Pharmacotherapy|January 1, 1994
Peripheral intravenous line survival and phlebitis prevention in patients receiving intravenous antibiotics: heparin/hydrocortisone versus in-line filtersG W Roberts, M D Holmes, R E Staugas, et al.
Pageof 14